It has long been known that insulin and glucose play a role in determining glucose uptake by the liver, but recently a third factor, related to portal vein glucose delivery, has been implicated as a physiologic regulator of net hepatic glucose uptake. During feeding the portal glucose level exceeds the arterial glucose concentration and the efficiency with which the liver extracts glucose is enhanced, and the way in which it disposes of the incoming glucose is modified. The hypothesis has been put forward that the portal vein and that this information is compared to input from arterial glucose sensors located elsewhere. We propose to use arterio- venous difference and tracer (radio and stable isotope) techniques to quantitate the metabolic response of the liver in conscious dogs during experiments aimed at furthering our understanding of the physiology of the """"""""portal"""""""" signal. The proposal has three main aims. First, we propose to further characterize the effect of the portal signal on the liver. We will assess the time course of the """"""""portal"""""""" effect on liver glucose uptake and its effect on the fate of glucose taken up by the liver glucose uptake and its effect on the fate of glucose taken up by the liver (conversion to lactate, oxidation, storage). We will also investigate the interrelationships between insulin, glucagon and the """"""""portal"""""""" signal. Second, we propose to test the hypothesis that the """"""""portal"""""""" signal is generated when the level of glucose in portal blood is compared to the glucose level in arterial blood reaching the brain. Third, we propose to determine the effect of the """"""""portal"""""""" signal in a situation when hormone levels and glucose production are increased (i.e. hypoglycemia) and its role in muscle and liver glycogen repletion following exercise. The proposed experiments will increase our understanding of the role of the liver in postprandial glucose disposal and should yield insight into the role of the nervous system in controlling fuel disposition after feeding.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043706-05
Application #
2143185
Study Section
Metabolism Study Section (MET)
Project Start
1991-04-01
Project End
1996-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Physiology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Kraft, Guillaume; Coate, Katie C; Winnick, Jason J et al. (2017) Glucagon's effect on liver protein metabolism in vivo. Am J Physiol Endocrinol Metab 313:E263-E272
Winnick, Jason J; An, Zhibo; Kraft, Guillaume et al. (2013) Liver glycogen loading dampens glycogen synthesis seen in response to either hyperinsulinemia or intraportal glucose infusion. Diabetes 62:96-101
Moore, Mary Courtney; Coate, Katie C; Winnick, Jason J et al. (2012) Regulation of hepatic glucose uptake and storage in vivo. Adv Nutr 3:286-94
Kraft, Guillaume; Coate, Katie C; Dardevet, Dominique et al. (2012) Portal glucose delivery stimulates muscle but not liver protein metabolism. Am J Physiol Endocrinol Metab 303:E1202-11
An, Zhibo; Winnick, Jason J; Moore, Mary C et al. (2012) A cyclic guanosine monophosphate-dependent pathway can regulate net hepatic glucose uptake in vivo. Diabetes 61:2433-41
Johnson, Kathryn M S; Farmer, Tiffany; Schurr, Kathleen et al. (2011) Endogenously released GLP-1 is not sufficient to alter postprandial glucose regulation in the dog. Endocrine 39:229-34
Winnick, Jason J; An, Zhibo; Ramnanan, Christopher J et al. (2011) Hepatic glycogen supercompensation activates AMP-activated protein kinase, impairs insulin signaling, and reduces glycogen deposition in the liver. Diabetes 60:398-407
An, Zhibo; Winnick, Jason J; Farmer, Ben et al. (2010) A soluble guanylate cyclase-dependent mechanism is involved in the regulation of net hepatic glucose uptake by nitric oxide in vivo. Diabetes 59:2999-3007
An, Zhibo; Moore, Mary C; Winnick, Jason J et al. (2009) Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs. Eur J Pharmacol 607:251-7
Winnick, Jason J; An, Zhibo; Moore, Mary Courtney et al. (2009) A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin. Am J Physiol Endocrinol Metab 297:E358-66

Showing the most recent 10 out of 62 publications